Status:
COMPLETED
Telmisartan Tab Hypertension
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
To assess the efficacy of telmisartan in hypertensive patients with high cardiovascular risk
Detailed Description
Study Design:
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Hypertensive patients with BP. 140/90mmHgand high and very high cardiovascular risk according to the ESH/ESC Guidelines 2007 and in whom the prescriber has taken the decision to start treatment with telmisartan 40 or 80 mg, with or without HCTZ 12.5 mg or 25 mg, in the usual way and in line with the SmPC and reimbursement criteria
- Exclusion criteria:
- Contra-indications as in the Summary of Product Characteristics
Exclusion
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
2913 Patients enrolled
Trial Details
Trial ID
NCT00890084
Start Date
April 1 2009
Last Update
April 8 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.